company background image
YPSN logo

Ypsomed Holding SWX:YPSN Stock Report

Last Price

CHF 390.50

Market Cap

CHF 5.2b

7D

4.3%

1Y

1.2%

Updated

28 May, 2025

Data

Company Financials +

YPSN Stock Overview

Develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. More details

YPSN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance1/6
Financial Health5/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Ypsomed Holding AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ypsomed Holding
Historical stock prices
Current Share PriceCHF 390.50
52 Week HighCHF 439.00
52 Week LowCHF 261.00
Beta1.14
1 Month Change14.01%
3 Month Change11.41%
1 Year Change1.17%
3 Year Change185.45%
5 Year Change189.26%
Change since IPO427.70%

Recent News & Updates

Earnings Miss: Ypsomed Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts

May 24
Earnings Miss: Ypsomed Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts

Returns At Ypsomed Holding (VTX:YPSN) Are On The Way Up

Apr 30
Returns At Ypsomed Holding (VTX:YPSN) Are On The Way Up

Recent updates

Earnings Miss: Ypsomed Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts

May 24
Earnings Miss: Ypsomed Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts

Returns At Ypsomed Holding (VTX:YPSN) Are On The Way Up

Apr 30
Returns At Ypsomed Holding (VTX:YPSN) Are On The Way Up

Shareholders Should Be Pleased With Ypsomed Holding AG's (VTX:YPSN) Price

Apr 12
Shareholders Should Be Pleased With Ypsomed Holding AG's (VTX:YPSN) Price

What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

Feb 23
What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Jan 23
We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Jan 09
Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Returns On Capital Are Showing Encouraging Signs At Ypsomed Holding (VTX:YPSN)

Dec 23
Returns On Capital Are Showing Encouraging Signs At Ypsomed Holding (VTX:YPSN)
author-image

GLP-1 Partnerships And Capacity Expansion To Drive Revenue Growth And Boost Margins

Ypsomed's shift to a B2B model and local manufacturing may streamline operations, improve focus, and reduce geopolitical risks, enhancing margins and earnings.

We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Nov 20
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

Nov 17
Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Aug 13
Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jul 31
There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Jul 03
If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Jun 19
Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Jun 10
Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Shareholder Returns

YPSNCH Medical EquipmentCH Market
7D4.3%-2.4%-0.5%
1Y1.2%-8.3%3.7%

Return vs Industry: YPSN exceeded the Swiss Medical Equipment industry which returned -8.3% over the past year.

Return vs Market: YPSN underperformed the Swiss Market which returned 3.7% over the past year.

Price Volatility

Is YPSN's price volatile compared to industry and market?
YPSN volatility
YPSN Average Weekly Movement5.3%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in CH Market9.5%
10% least volatile stocks in CH Market2.5%

Stable Share Price: YPSN has not had significant price volatility in the past 3 months compared to the Swiss market.

Volatility Over Time: YPSN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19842,644Simon Michelwww.ypsomed.com

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.

Ypsomed Holding AG Fundamentals Summary

How do Ypsomed Holding's earnings and revenue compare to its market cap?
YPSN fundamental statistics
Market capCHF 5.24b
Earnings (TTM)CHF 87.50m
Revenue (TTM)CHF 748.87m
60.9x
P/E Ratio
7.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
YPSN income statement (TTM)
RevenueCHF 748.87m
Cost of RevenueCHF 456.80m
Gross ProfitCHF 292.07m
Other ExpensesCHF 204.56m
EarningsCHF 87.50m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Nov 12, 2025

Earnings per share (EPS)6.41
Gross Margin39.00%
Net Profit Margin11.68%
Debt/Equity Ratio39.3%

How did YPSN perform over the long term?

See historical performance and comparison

Dividends

0.6%
Current Dividend Yield
34%
Payout Ratio

Does YPSN pay a reliable dividends?

See YPSN dividend history and benchmarks
When do you need to buy YPSN by to receive an upcoming dividend?
Ypsomed Holding dividend dates
Ex Dividend DateJul 04 2025
Dividend Pay DateJul 08 2025
Days until Ex dividend36 days
Days until Dividend pay date40 days

Does YPSN pay a reliable dividends?

See YPSN dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/28 18:33
End of Day Share Price 2025/05/28 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ypsomed Holding AG is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gaurav JainBarclays
Hugo SolvetBNP Paribas Exane
Curtis MoilesBNP Paribas Exane